Clinical study on the treatment of qi stagnation and phlegm obstruction dyslipidemia with Jieyu Qutan Huazhuo prescription

Guang'anmen Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Aged between 18 and 80;
•(2) Meet the diagnostic criteria of hypertriglyceridemia;
•(3) Meet the diagnostic criteria of qi stagnation and phlegm obstruction syndrome;
•(4) Those who are using other lipid-lowering drugs or therapies (including physical therapy) should stop taking the drugs or stop the therapy and still meet the above standards after 2 weeks of elution;
•(5) Voluntarily join the study and sign the informed consent.

•(1) Secondary hypertriglyceridemia caused by hypothyroidism, nephrotic syndrome, diabetes and other diseases;
•(2) Have suffered from acute cardiovascular and cerebrovascular events or severe trauma within 1 year;
•(3) Patients who need to take drugs with definite influence on triglyceride level for a long time after previous PCI or other major surgery;
•(4) Patients suffering from systemic serious diseases of the heart, brain, liver, kidney and immune system, or mental patients;
•(5) The patient is using drugs that affect lipid metabolism, such as glucocorticoids, thyroid hormones, and moderate potency diuretics
•(6) The patient or his/her spouse is in the stage of pregnancy, pregnancy or lactation;
•(7) People who may be allergic to the drug in this test;
•(8) Other circumstances that may affect the efficacy and safety of the test drug.

发起方